<code id='FA3B6F8E8E'></code><style id='FA3B6F8E8E'></style>
    • <acronym id='FA3B6F8E8E'></acronym>
      <center id='FA3B6F8E8E'><center id='FA3B6F8E8E'><tfoot id='FA3B6F8E8E'></tfoot></center><abbr id='FA3B6F8E8E'><dir id='FA3B6F8E8E'><tfoot id='FA3B6F8E8E'></tfoot><noframes id='FA3B6F8E8E'>

    • <optgroup id='FA3B6F8E8E'><strike id='FA3B6F8E8E'><sup id='FA3B6F8E8E'></sup></strike><code id='FA3B6F8E8E'></code></optgroup>
        1. <b id='FA3B6F8E8E'><label id='FA3B6F8E8E'><select id='FA3B6F8E8E'><dt id='FA3B6F8E8E'><span id='FA3B6F8E8E'></span></dt></select></label></b><u id='FA3B6F8E8E'></u>
          <i id='FA3B6F8E8E'><strike id='FA3B6F8E8E'><tt id='FA3B6F8E8E'><pre id='FA3B6F8E8E'></pre></tt></strike></i>

          leisure time

          leisure time

          author:knowledge    Page View:894
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more
          Adam's Biotech Scorecard: Do Sarepta's exon
          Adam's Biotech Scorecard: Do Sarepta's exon

          ThisistheonlineeditionofAdam’sBiotechScorecard,asubscriber-onlynewsletter.STAT+subscriberscansignuph

          read more
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more

          Merus drug and Keytruda shrank tumors in patients with head and neck cancer

          ThisimmunofluorescenceimageshowsTcells(ingreenandyellow)inthemicroenvironmentofaheadandnecksquamousc